gvtcx

Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.

UNIVERSITY OF NOTTINGHAM (THE) Published 27 Jan 2023 Contracts Finder

key details

Value£76,536
Statuscomplete
Category (CPV) 73100000
RegionEast Midlands
Deadline4 May 2022
Contract start5 May 2022
Contract end5 May 2022
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-74cf7efb-12b0-4713-adbc-9ac8b71113ed

Award

SupplierValueDateStatus
MEDICINES DISCOVERY CATAPULT SERVICES LIMITED £76,536 4 May 2022 active

description

The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
27 Jan 2023 Award update (awardUpdate) · b7fe11c2-b9bc-4f06-8d38-f5d56d677deb-609355

more from UNIVERSITY OF NOTTINGHAM (THE)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.